Search Within

HEMATOLOGICAL MALIGNANCIES

Vaccine and Cell-Based Therapeutic Approaches in Acute Myeloid Leukemia

Journal: Current Cancer Drug Targets
Volume: 20, Issue: 7
Page: 473-489
Authors: Vaibhav Agrawal*, Olumide B. Gbolahan, Maximilian Stahl, Amer M. Zeidan, Mohammad Abu Zaid, Sherif S. Farag and Heiko Konig*

Pure Red Cell Aplasia Caused by Azathioprine

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 20, Issue: 2
Page: 164-165
Authors: Dimitris Kounatidis, Natalia Vallianou*, Vasiliki Daskalaki, Christos Masaoutis, Evangelia Margellou, Nikos Harhalakis and Evangelos Kokkinakis

The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 20, Issue: 6
Page: 700-708
Authors: Mitra Korani, Sara Nikoofal-Sahlabadi, Amin R. Nikpoor, Solmaz Ghaffari, Hossein Attar, Mohammad Mashreghi and Mahmoud R. Jaafari*

Regulatory T Cell Counts and Development of Malignancy in Patients with HIV Infection

Journal: Current HIV Research
Volume: 18, Issue: 3
Page: 201-209
Authors: Marianna Politou, Sofia Boti, Theodoros Androutsakos*, Athanasios Kontos, Abraham Pouliakis, Violetta Kapsimali, George Panayiotakopoulos, Theodore Kordossis, Petros Karakitsos and Nikolaos V. Sipsas

Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents

Journal: Current Medicinal Chemistry
Volume: 27, Issue: 15
Page: 2449-2493
Authors: Loredana Cappellacci*, Diego R. Perinelli, Filippo Maggi, Mario Grifantini and Riccardo Petrelli*

Pharmacokinetics and Systems Pharmacology of Anti-CD47 Macrophage Immune Checkpoint Inhibitor Hu5F9-G4

Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 17, Issue: 1
Page: 14-24
Authors: Adarsh Mishra, Ishant Kataria and Sujit Nair*

A Review of Evaluating Hematopoietic Stem Cells Derived from Umbilical Cord Blood's Expansion and Homing

Journal: Current Stem Cell Research & Therapy
Volume: 15, Issue: 3
Page: 250-262
Authors: Maryam Islami* and Fatemeh Soleimanifar

The Role of TRP Channels in Allergic Inflammation and its Clinical Relevance

Journal: Current Medicinal Chemistry
Volume: 27, Issue: 9
Page: 1446-1468
Authors: Joo Hyun Nam and Woo Kyung Kim*

Sam Domains in Multiple Diseases

Journal: Current Medicinal Chemistry
Volume: 27, Issue: 3
Page: 450-476
Authors: Marian Vincenzi, Flavia Anna Mercurio and Marilisa Leone*

Impact of Natural Dietary Agents on Multiple Myeloma Prevention and Treatment: Molecular Insights and Potential for Clinical Translation

Journal: Current Medicinal Chemistry
Volume: 27, Issue: 2
Page: 187-215
Authors: Lavinia Raimondi, Angela De Luca, Gianluca Giavaresi, Agnese Barone, Pierosandro Tagliaferri, Pierfrancesco Tassone and Nicola Amodio*

Role of microRNAs in Chronic Lymphocytic Leukemia Pathogenesis

Journal: Current Medicinal Chemistry
Volume: 27, Issue: 2
Page: 282-297
Authors: Ehsan Javandoost, Ehsan Firoozi-Majd, Hosein Rostamian, Mohammad Khakpoor- Koosheh and Hamid Reza Mirzaei*

Novel Mechanistic Insights into the Anti-cancer Mode of Arsenic Trioxide

Journal: Current Cancer Drug Targets
Volume: 20, Issue: 2
Page: 115-129
Authors: Md Wahiduzzaman, Akinobu Ota* and Yoshitaka Hosokawa

STAT5 and STAT5 Inhibitors in Hematological Malignancies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 19, Issue: 17
Page: 2036-2046
Authors: Manlio Tolomeo*, Maria Meli and Stefania Grimaudo

Zinc Dependent Histone Deacetylase Inhibitors in Cancer Therapeutics: Recent Update

Journal: Current Medicinal Chemistry
Volume: 26, Issue: 40
Page: 7212-7280
Authors: Faria Sultana, Kesari Lakshmi Manasa, Siddiq Pasha Shaik, Srinivasa Reddy Bonam and Ahmed Kamal*

Mechanism and Treatment of Rituximab Resistance in Diffuse Large Bcell Lymphoma

Journal: Current Cancer Drug Targets
Volume: 19, Issue: 9
Page: 681-687
Authors: Linqing Zou, Guoqi Song, Siyu Gu, Lingling Kong, Shiqi Sun, Li Yang* and William C. Cho*

Aim for the Readers! Bromodomains As New Targets Against Chagas’ Disease

Journal: Current Medicinal Chemistry
Volume: 26, Issue: 36
Page: 6544-6563
Authors: Victoria Lucia Alonso, Luis Emilio Tavernelli, Alejandro Pezza, Pamela Cribb, Carla Ritagliati and Esteban Serra*

Drug Repurposing Screen Identifies Novel Classes of Drugs with Anticancer Activity in Mantle Cell Lymphoma

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 22, Issue: 7
Page: 483-495
Authors: Chengwu Han, Xueying Yu, Chunxia Zhang, Ying Cai, Yongyue Cao, Sijie Wang and Jun Shen*

HLAs in Autoimmune Diseases: Dependable Diagnostic Biomarkers?

Journal: Current Rheumatology Reviews
Volume: 15, Issue: 4
Page: 269-276
Authors: Elham Rajaei, Mohammad Taha Jalali, Saeid Shahrabi, Ali Amin Asnafi and Seyed Mohammad Sadegh Pezeshki*

Opioid Free Anaesthesia and Cancer

Journal: Current Pharmaceutical Design
Volume: 25, Issue: 28
Page: 3011-3019
Authors: Alfredo Malo-Manso*, Aida Raigon-Ponferrada*, Julia Diaz-Crespo, Juan J. Escalona-Belmonte, Jose Cruz-Mañas and Jose L. Guerrero-Orriach

CD123: A Novel Biomarker for Diagnosis and Treatment of Leukemia

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 19, Issue: 3
Page: 195-204
Authors: Mingyue Shi, Ruijun J. Su, Kamal-Preet Parmar, Rahman Chaudhry, Kai Sun, Jianyu Rao and Mingyi Chen*

International Publication Trends in Proteasome Inhibitors: From Tools for Cell Biologists to Anticancer Agents

Journal: Letters in Drug Design & Discovery
Volume: 16, Issue: 9
Page: 1031-1039
Authors: Peng Zhou, Minhui Zhu, Caiyun Zhang, Donghui Chen and Hongliang Zheng*

STAT3: A Potential Drug Target for Tumor and Inflammation

Journal: Current Topics in Medicinal Chemistry
Volume: 19, Issue: 15
Page: 1305-1317
Authors: Yang Sheng Hu, Xu Han and Xin Hua Liu*

Perspectives and New Aspects of Metalloproteinases’ Inhibitors in the Therapy of CNS Disorders: From Chemistry to Medicine

Journal: Current Medicinal Chemistry
Volume: 26, Issue: 18
Page: 3208-3224
Authors: Anna Boguszewska-Czubara*, Barbara Budzynska, Krystyna Skalicka-Wozniak and Jacek Kurzepa

Adoptive Immunotherapy for B-cell Malignancies Using CD19- Targeted Chimeric Antigen Receptor T-Cells: A Systematic Review of Efficacy and Safety

Journal: Current Medicinal Chemistry
Volume: 26, Issue: 17
Page: 3068-3079
Authors: Lu Hao, Tongtong Li, Lung-Ji Chang* and Xiaochuan Chen*

Targeting p53-MDM2 Interaction Using Small Molecule Inhibitors and the Challenges Needed to be Addressed

Journal: Current Drug Targets
Volume: 20, Issue: 11
Page: 1091-1111
Authors: Maryam Zanjirband* and Soheila Rahgozar

PPARγ: Potential Therapeutic Target for Ailments Beyond Diabetes and its Natural Agonism

Journal: Current Drug Targets
Volume: 20, Issue: 12
Page: 1281-1294
Authors: Sana Shafi, Pawan Gupta, Gopal Lal Khatik and Jeena Gupta*

Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 14, Issue: 2
Page: 113-132
Authors: Elmira Ekinci, Sagar Rohondia, Raheel Khan and Qingping P. Dou*

An Overview of HDAC Inhibitors and their Synthetic Routes

Journal: Current Topics in Medicinal Chemistry
Volume: 19, Issue: 12
Page: 1005-1040
Authors: Xiaopeng Peng, Guochao Liao, Pinghua Sun, Zhiqiang Yu and Jianjun Chen*

Research Advances in the Use of Histone Deacetylase Inhibitors for Epigenetic Targeting of Cancer

Journal: Current Topics in Medicinal Chemistry
Volume: 19, Issue: 12
Page: 995-1004
Authors: Yu Bai, Daid Ahmad, Ting Wang*, Guihua Cui and Wenliang Li*

The Role of AMPK/mTOR Modulators in the Therapy of Acute Myeloid Leukemia

Journal: Current Medicinal Chemistry
Volume: 26, Issue: 12
Page: 2208-2229
Authors: Dora Visnjic*, Vilma Dembitz and Hrvoje Lalic

Protective Role of Silymarin in Early Doxorubicin-induced Cardiac Dysfunction in Children with Acute Lymphoblastic Leukemia

Journal: Infectious Disorders - Drug Targets
Volume: 19, Issue: 2
Page: 133-140
Authors: Adel A. Hagag*, Walid A. El Shehaby, Aml I. El-Abasy and Maaly M. Mabrouk

DNA Double Strand Break Repair - Related Synthetic Lethality

Journal: Current Medicinal Chemistry
Volume: 26, Issue: 8
Page: 1446-1482
Authors: Monika Toma, Tomasz Skorski* and Tomasz Sliwinski*

Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics

Journal: Current Medicinal Chemistry
Volume: 26, Issue: 8
Page: 1328-1350
Authors: Yinglu Li, Zhiming Li and Wei-Guo Zhu*

Biological Therapy of Hematologic Malignancies: Toward a Chemotherapy- free Era

Journal: Current Medicinal Chemistry
Volume: 26, Issue: 6
Page: 1002-1018
Authors: Pavel Klener Jr, Tomas Etrych and Pavel Klener*

Cellular Senescence and Anti-Cancer Therapy

Journal: Current Drug Targets
Volume: 20, Issue: 7
Page: 705-715
Authors: Jieqiong You, Rong Dong, Meidan Ying, Qiaojun He, Ji Cao * and Bo Yang*

Toxicology of Trastuzumab: An Insight into Mechanisms of Cardiotoxicity

Journal: Current Cancer Drug Targets
Volume: 19, Issue: 5
Page: 400-407
Authors: Jie An* and M. Saeed Sheikh*

Invasive Fungal Infection in Febrile Patients with Hematologic Malignancies Undergoing Chemotherapy in Iran

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 19, Issue: 3
Page: 302-307
Authors: Saba Sheikhbahaei, Alireza Mohammadi, Roya Sherkat*, Alireza Emami Naeini, Majid Yaran and Somaye Najafi

Radionuclide-Labeled Peptides for Imaging and Treatment of CXCR4- Overexpressing Malignant Tumors

Journal: Current Topics in Medicinal Chemistry
Volume: 19, Issue: 1
Page: 17-32
Authors: Nan Liu*, Qiang Wan, Zhen Cheng and Yue Chen

Chlorambucil Cytotoxicity Reduction in Rats Through Bone Marrow, An In vivo Study

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18, Issue: 15
Page: 2187-2192
Authors: Ebtesam H.O. Nafie*, Eman Khater, Mohamed Awwad, Mohamed Zowail and Kholud Hegazy

Pleiotropic Effect of Mahanine and Girinimbine Analogs: Anticancer Mechanism and its Therapeutic Versatility

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18, Issue: 14
Page: 1983-1990
Authors: V. Lenin Maruthanila, Ramakrishnan Elancheran*, Ajaikumar B. Kunnumakkar, Senthamaraikannan Kabilan and Jibon Kotoky*

Enasidenib: First Mutant IDH2 Inhibitor for the Treatment of Refractory and Relapsed Acute Myeloid Leukemia

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18, Issue: 14
Page: 1936-1951
Authors: Raghav Dogra, Rohit Bhatia, Ravi Shankar, Parveen Bansal and Ravindra K. Rawal*

Current Understanding of the Potential of Proteomics and Metabolomics Approaches in Cancer Chemoresistance: A Focus on Multiple Myeloma

Journal: Current Topics in Medicinal Chemistry
Volume: 18, Issue: 30
Page: 2584-2598
Authors: Venkatesh Chanukuppa, Ravindra Taware, Tathagat Chatterjee, Sanjeevan Sharma, Tushar H. More, Khushman Taunk, Saravanan Kumar, Manas K. Santra and Srikanth Rapole*

Epigenetic Targets and their Inhibitors in Cancer Therapy

Journal: Current Topics in Medicinal Chemistry
Volume: 18, Issue: 28
Page: 2395-2419
Authors: Le Zhao, Yong-Tao Duan, Ping Lu, Zhi-Juan Zhang, Xiao-Ke Zheng, Jun-Lei Wang* and Wei-Sheng Feng*

DNA Methyltransferase Inhibitors and their Therapeutic Potential

Journal: Current Topics in Medicinal Chemistry
Volume: 18, Issue: 28
Page: 2448-2457
Authors: Zehao Zhou, Huan-Qiu Li* and Feng Liu*

Exploring the Lapse in Druggability: Sequence Analysis, Structural Dynamics and Binding Site Characterization of K-RasG12C Variant, a Feasible Oncotherapeutics Target

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18, Issue: 11
Page: 1540-1550
Authors: Emmanuel A. Adeniji, Fisayo A. Olotu and Mahmoud E.S. Soliman*

Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 19, Issue: 1
Page: 51-78
Authors: Ota Fuchs*

Antitumor Effect of Pomolic Acid in Acute Myeloid Leukemia Cells Involves Cell Death, Decreased Cell Growth and Topoisomerases Inhibition

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18, Issue: 10
Page: 1457-1468
Authors: Michelle X.G. Pereira, Amanda S.O. Hammes, Flavia C. Vasconcelos, Aline R. Pozzo, Thaís H. Pereira, Ernesto R. Caffarena, Cerli R. Gattass and Raquel C. Maia*

Combination Treatment of p53-Null HL-60 cells with Histone Deacetylase Inhibitors and Chlorambucil Augments Apoptosis and Increases BCL6 and p21 Gene Expression

Journal: Current Molecular Pharmacology
Volume: 12, Issue: 1
Page: 72-81
Authors: Faith A.A. Kwa*, Merrole F. Cole-Sinclair and Miroslav K. Kapuscinski

RO3280: A Novel PLK1 Inhibitor, Suppressed the Proliferation of MCF-7 Breast Cancer Cells Through the Induction of Cell Cycle Arrest at G2/M Point

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 19, Issue: 15
Page: 1846-1854
Authors: Mustafa Ergul* and Filiz Bakar-Ates

Potential Pharmacological Inhibitors of Pim Kinase Under Clinical Trials

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18, Issue: 8
Page: 1100-1114
Authors: Gomathi P. Jeyapal, Moola J.N. Chandrasekar*, Rajendiran Krishnasamy, Jubie Selvaraj, Manal Mohammad and Moola J. Nanjan

Endothelial and Circulating Progenitor Cells in Hematological Diseases and Allogeneic Hematopoietic Stem Cell Transplantation

Journal: Current Medicinal Chemistry
Volume: 25, Issue: 35
Page: 4535-4544
Authors: Annalisa Ruggeri*, Annalisa Paviglianiti, Fernanda Volt, Chantal Kenzey, Hanadi Rafii, Vanderson Rocha and Eliane Gluckman

Gastroduodenal Disorders in Patients with CVID Undergoing Immunoglobulin Therapy

Journal: Current Pharmaceutical Biotechnology
Volume: 19, Issue: 9
Page: 734-741
Authors: Gilda Varricchi*, Antonio Pecoraro*, Ludovica Crescenzi, Giancarlo Marone, Antonio Travaglino, Francesco Paolo D'Armiento, Arturo Genovese and Giuseppe Spadaro

Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic Malignancies

Journal: Current Radiopharmaceuticals
Volume: 11, Issue: 3
Page: 192-199
Authors: Joseph G. Jurcic*

Relevance of Breast Cancer Resistance Protein to Brain Distribution and Central Acting Drugs: A Pharmacokinetic Perspective

Journal: Current Drug Metabolism
Volume: 19, Issue: 12
Page: 1021-1041
Authors: Joana Goncalves, Joana Bicker, Gilberto Alves, Ana Fortuna* and Amilcar Falcao

IAP Proteins Antagonist: An Introduction and Chemistry of Smac Mimetics under Clinical Development

Journal: Current Medicinal Chemistry
Volume: 25, Issue: 31
Page: 3768-3795
Authors: Rafat Ali, Shalini Singh and Wahajul Haq*

Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13, Issue: 4
Page: 455-468
Authors: Weidong Li and Xueying Sun*

Signal Transduction through JAK-STAT and NF-κB Regulated Pim-1 Kinase: Novel Target for Anticancer Leads

Journal: Current Signal Transduction Therapy
Volume: 13, Issue: 2
Page: 83-104
Authors: Sisir Nandi*, Mohd Salman, Ankita Sharma and Mohit Kumar

Significant Role of MUC1 in Development of Resistance to Currently Existing Anti-cancer Therapeutic Agents

Journal: Current Cancer Drug Targets
Volume: 18, Issue: 8
Page: 737-748
Authors: Leila Farahmand, Parnaz Merikhian, Neda Jalili, Behrad Darvishi and Keivan Majidzadeh-A*

Recent Progress in Clinical Development of Therapeutic Antibodies Targeting Glycan-Binding Proteins

Journal: Current Drug Targets
Volume: 19, Issue: 13
Page: 1491-1497
Authors: Qun Zhou*

Pegylated Naloxone in the Treatment of Persistent Opioid-Induced Constipation in Patients with Hematological Malignancies

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 16, Issue: 1
Page: 3-4
Authors: Gregorio Antonio Brunetti, Giovanna Palumbo, Giorgia Annechini, Michelina Santopietro, Andrea Tendas*, Pasquale Niscola* and Claudio Cartoni

Biological Agents in Rheumatoid Arthritis: A Cross-Link Between Immune Tolerance and Immune Surveillance

Journal: Current Rheumatology Reviews
Volume: 14, Issue: 2
Page: 131-139
Authors: Rossella Talotta*, Fabiola Atzeni, Alberto Batticciotto, Maurizio Benucci, Sara Bongiovanni and Piercarlo Sarzi-Puttini

Targeting Kinase-activating Genetic Lesions to Improve Therapy of Pediatric Acute Lymphoblastic Leukemia

Journal: Current Medicinal Chemistry
Volume: 25, Issue: 24
Page: 2811-2825
Authors: Raffaella Franca, Natasa K. Kuzelicki, Claudio Sorio, Eleonora Toffoletti, Oksana Montecchini, Alice Poropat, Marco Rabusin*, Debora Curci, Dino Paladin, Gabriele Stocco and Giuliana Decorti

CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell Death

Journal: Current Cancer Drug Targets
Volume: 18, Issue: 6
Page: 608-616
Authors: Elisa Mandato, Sara Canovas Nunes, Fortunato Zaffino, Alessandro Casellato, Paolo Macaccaro, Laura Quotti Tubi, Andrea Visentin, Livio Trentin, Gianpietro Semenzato and Francesco Piazza*

CAR T-cell Therapy: A New Era in Cancer Immunotherapy

Journal: Current Pharmaceutical Biotechnology
Volume: 19, Issue: 1
Page: 5-18
Authors: Androulla N. Miliotou and Lefkothea C. Papadopoulou*

Chimeric Antigen Receptor T Cell Based Immunotherapy for Cancer

Journal: Current Stem Cell Research & Therapy
Volume: 13, Issue: 5
Page: 327-335
Authors: Feng Li, Tengfei Zhang, Ling Cao and Yi Zhang*

Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy

Journal: Current Cancer Drug Targets
Volume: 18, Issue: 5
Page: 499-511
Authors: Raffaele Di Francia*, Angela De Monaco, Mariangela Saggese, Giancarla Iaccarino, Stefania Crisci, Ferdinando Frigeri, Rosaria De Filippi, Massimiliano Berretta and Antonio Pinto

Aurora Kinase Inhibitors in Head and Neck Cancer

Journal: Current Topics in Medicinal Chemistry
Volume: 18, Issue: 3
Page: 199-213
Authors: Guangying Qi, Jing Liu, Sisi Mi, Takaaki Tsunematsu, Shengjian Jin, Wenhua Shao, Tian Liu, Naozumi Ishimaru, Bo Tang* and Yasusei Kudo*

Advances in the Discovery of Anthraquinone-Based Anticancer Agents

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13, Issue: 2
Page: 159-183
Authors: Alexander S. Tikhomirov*, Alexander A. Shtil and Andrey E. Shchekotikhin

In-silico Evidences of Regulatory Roles of WT1 Transcription Factor Binding Sites on the Intervening Sequences of the Human Bcl-2 Gene

Journal: Current Bioinformatics
Volume: 13, Issue: 3
Page: 260-272
Authors: Gholampour-Faroji Nazanin, Haddad-Mashadrizeh Aliakbar*, Mirahmadi Mahdi, Monhemi Hassan, Shahreki-Mojahed Safoora, Bahrami Ahmad Reza, Housaindokht Mohammadreza, Matin M. Maryam, Zomorodipour Alireza, Dadjoo Parisa and Nohtani Mahdi

Effect and Mechanism of Curcumin on EZH2 - miR-101 Regulatory Feedback Loop in Multiple Myeloma

Journal: Current Pharmaceutical Design
Volume: 24, Issue: 5
Page: 564-575
Authors: Chuanqing Wu, Tuo Ruan, Weizhen Liu, Xiaojie Zhu, Juan Pan, Wen Lu, Chen Yan, Kaixiong Tao , Weikang Zhang* and Chun Zhang*

Recent Synthetic Strategies for Monocyclic Azole Nucleus and Its Role in Drug Discovery and Development

Journal: Current Organic Synthesis
Volume: 15, Issue: 3
Page: 321-340
Authors: Neha, Ashish Ranjan Dwivedi, Rakesh Kumar* and Vinod Kumar*

Adverse Events of Proton Pump Inhibitors: Potential Mechanisms

Journal: Current Drug Metabolism
Volume: 19, Issue: 2
Page: 142-154
Authors: Andrea Corsonello*, Fabrizia Lattanzio, Silvia Bustacchini, Sabrina Garasto, Annalisa Cozza, Roberto Schepisi, Federica Lenci, Filippo Luciani, Marcello Giuseppe Maggio, Andrea Ticinesi, Valeria Butto, Sara Tagliaferri and Francesco Corica

VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy

Journal: Current Molecular Medicine
Volume: 17, Issue: 9
Page: 608-618
Authors: B. Lan, S. Chai, P. Wang* and K. Wang*

A High-throughput Screening of a Chemical Compound Library in Ovarian Cancer Stem Cells

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 21, Issue: 1
Page: 50-56
Authors: F. Ricci*, L. Carrassa, M. S. Christodoulou, D. Passarella, B. Michel, R. Benhida, N. Martinet, A. Hunyadi, E. Ioannou, V. Roussis, L. Musso, S. Dallavalle, R. Silvestri, N. Westwood, M. Mori, C. Ingallina, B. Botta, E. Kavetsou, A. Detsi, Z. Majer, F. Hudecz, S. Bosze, B. Kaminska, T.V. Hansen, P. Bertrand, C. M. Athanassopoulos and G. Damia*

Tumor-Targeting Peptides: Ligands for Molecular Imaging and Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18, Issue: 1
Page: 74-86
Authors: Ning Zhao, Yeshan Qin, Hongguang Liu* and Zhen Cheng*

Obesity and Cancer: Biological Links and Treatment Implications

Journal: Current Cancer Drug Targets
Volume: 18, Issue: 3
Page: 231-238
Authors: Alessandro Ottaiano*, Chiara De Divitiis, Monica Capozzi, Antonio Avallone, Carmen Pisano, Sandro Pignata and Salvatore Tafuto

Cardiovascular Events: A Challenge in JAK2-positive Myeloproliferative Neoplasms

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 17, Issue: 3
Page: 161-166
Authors: Habib Haybar, Elahe Khodadi, Mohammad Shahjahani and Najmaldin Saki*

Synthesis of Pyridine and Spiropyridine Derivatives Derived from 2-aminoprop- 1-ene-1,1,3-tricarbonitrile Together with their c-Met Kinase and Antiproliferative Evaluations

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17, Issue: 14
Page: 1951-1962
Authors: Rafat M. Mohareb*, Amr S. Abouzied and Nermeen S. Abbas

Detection of Formation of Recombinant Human Keratinocyte Growth Factor Loaded Chitosan Nanoparticles Based on its Optical Properties

Journal: Current Nanoscience
Volume: 14, Issue: 2
Page: 127-135
Authors: Palanirajan Vijayaraj Kumar*, Marwan Abdelmahmoud Abdelkarim Maki, Mhd Luay Takahje, Yeong Siew Wei, Lee Ming Tatt and Abu Bakar Bin Abdul Majeed

Doxycycline as Potential Anti-cancer Agent

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17, Issue: 12
Page: 1617-1623
Authors: Isra Ali*, Khalid O. Alfarouk*, Stephan J. Reshkin and Muntaser E. Ibrahim

Myc Decoy Oligodeoxynucleotide Inhibits Growth and Modulates Differentiation of Mouse Embryonic Stem Cells as a Model of Cancer Stem Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17, Issue: 13
Page: 1786-1795
Authors: Behrooz Johari, Mina Ebrahimi-Rad, Faezeh Maghsood, Majid Lotfinia, Zohreh Saltanatpouri, Ladan Teimoori-Toolabi, Zahra Sharifzadeh, Morteza Karimipoor and Mehdi Kadivar*

Cell Cycle Arrest and Apoptosis Induction Activity of Nitidine Chloride on Acute Myeloid Leukemia Cells

Journal: Medicinal Chemistry
Volume: 14, Issue: 1
Page: 60-66
Authors: Peng Li, Shuxin Yan, Xin Dong, Zhao Li, Yu Qiu, Chunyan Ji, Jingru Zhang, Min Ji, Wei Li, Hongchun Wang, Zhi Liu, Xing L. Wang, Jingjing Ye* and Daoxin Ma

Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 18, Issue: 2
Page: 173-183
Authors: Voon Yee-Lin*, Wong Pooi-Fong and Alan Khoo Soo-Beng

Natural Product Inhibitors of Histone Deacetylases as New Anticancer Agents

Journal: Current Protein & Peptide Science
Volume: 19, Issue: 3
Page: 333-340
Authors: Aysegul Hanikoglu, Ferhat Hanikoglu and Tomris Ozben*

Multimodal HDAC Inhibitors with Improved Anticancer Activity

Journal: Current Cancer Drug Targets
Volume: 18, Issue: 1
Page: 39-56
Authors: Rainer Schobert and Bernhard Biersack*

Post-Transcriptional and Post-translational Regulation of Central Carbon Metabolic Enzymes in Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17, Issue: 11
Page: 1456-1465
Authors: Yunqian Wang, Yingxuan Chen* and Jingyuan Fang

Chemical Space of FLT3 Inhibitors as Potential Anti-AML Drugs

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 12, Issue: 4
Page: 296-322
Authors: Qing-Yuan Lan, Yan-Le Zhi, Hao Heng, Jie-Yi Tian, Xiao-Xing Guo, Hai-Chun Liu, Ya-Dong Chen, Tao Lu* and Shuai Lu*

Induction of Synthetic Lethality by Natural Compounds Targeting Cancer Signaling

Journal: Current Pharmaceutical Design
Volume: 23, Issue: 29
Page: 4311-4320
Authors: Lee Farrand and Sanguine Byun*

Protein Tyrosine Signaling and its Potential Therapeutic Implications in Carcinogenesis

Journal: Current Pharmaceutical Design
Volume: 23, Issue: 29
Page: 4226-4246
Authors: Mihwa Kim, Minwoo Baek and Dae Joon Kim*

Emerging Family of Protein-protein Interaction Inhibitors Targeting PD-1 Checkpoint Pathway

Journal: Current Cancer Therapy Reviews
Volume: 13, Issue: 2
Page: 120-128
Authors: Yijun Huang* and Hong Zhang

Status Quo in Antibody-Drug Conjugates - Can Glyco- Enzymes Solve the Current Challenges?

Journal: Protein & Peptide Letters
Volume: 24, Issue: 8
Page: 686-695
Authors: Florentina Kubizek, Britta Eggenreich and Oliver Spadiut*

L-Tetrahydropalmatine Induces Apoptosis in EU-4 Leukemia Cells by Down-Regulating X-Linked Inhibitor of Apoptosis Protein and Increases the Sensitivity Towards Doxorubicin

Journal: Current Molecular Medicine
Volume: 17, Issue: 3
Page: 236-245
Authors: S. Li, D. Chen, R. Pei *, Y. Lu*, P. Zhang, J. Ma, X. Liu, X. Du, K. Sha, L. Chen, J. Cao, X. Zhuang, J. Wu, L. Lin, Z. Fan, P. Ye, S. Tang, B. Zhang, X. Shi and K. Li

Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment

Journal: Current Cancer Drug Targets
Volume: 17, Issue: 9
Page: 819-838
Authors: Cirino Botta, Maria Cuce, Daniele Caracciolo, Lucia Fiorillo, Pierosandro Tagliaferri and Pierfrancesco Tassone*

Multiple Myeloma and the Immune Microenvironment

Journal: Current Cancer Drug Targets
Volume: 17, Issue: 9
Page: 806-818
Authors: Yawara Kawano, Aldo. M. Roccaro, Irene M. Ghobrial* and Jamil Azzi*

Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma

Journal: Current Cancer Drug Targets
Volume: 17, Issue: 9
Page: 782-805
Authors: K. Podar* and D. Jager

Coinhibitory Molecule PD-1 as a Therapeutic Target in the Microenvironment of Multiple Myeloma

Journal: Current Cancer Drug Targets
Volume: 17, Issue: 9
Page: 839-845
Authors: Djordje Atanackovic, Tim Luetkens, Sabari Radhakrishnan and Nicolaus Kroger*

Infection and Malignancy Risk in Patients Treated with TNF Inhibitors for Immune-Mediated Inflammatory Diseases

Journal: Current Drug Safety
Volume: 12, Issue: 3
Page: 162-170
Authors: Rui Pereira, Raquel Faria, Paula Lago and Tiago Torres*

Nano-Delivery in Pediatric Tumors: Looking Back, Moving Forward

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17, Issue: 10
Page: 1328-1343
Authors: Marta Colletti, Virginia Di Paolo, Angela Galardi, Giuseppe Maria Milano, Angela Mastronuzzi, Franco Locatelli and Angela Di Giannatale*

Major Highlights of the CAR-TCR Summit, Boston, 2016

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17, Issue: 10
Page: 1344-1350
Authors: Vita Golubovskaya*, Robert Berahovich, Shirley Xu, Hizkia Harto and Lijun Wu*

Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors

Journal: Current Medicinal Chemistry
Volume: 24, Issue: 28
Page: 3025-3053
Authors: Agnieszka Dreas, Maciej Mikulski, Mariusz Milik, Charles-Henry Fabritius, Krzysztof Brzózka and Tomasz Rzymski*